Annovis Bio, Inc. (ANVS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Annovis Bio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.46x | -2.49x | -3.00x | -4.33x | -9.25x | -8.71x |
| P/B Ratio | 4.22x | 6.58x | -21.77x | 3.87x | 3.01x | 6.31x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.80x | 3.59x | 2.39x | 4.68x | 30.54x | 14.04x |
| Quick Ratio | 5.80x | 3.59x | 2.39x | 4.68x | 30.54x | 14.04x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..